Products
Services
Resources
Selection Guides
About
Dual specificity phosphatase 22 Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | 4-[5-(4-Fluorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]benzoic acid | IC50 | 4200.0 [1] |
 | 4-[(5Z)-5-Benzylidene-4-oxo-2-thioxo-1,3-thiazolidin-3-YL]benzoic acid | IC50 | 18000.0 [1] |
 | 1-N-[2,3-Bis(furan-2-yl)quinoxalin-6-yl]-3-N,3-N-diethylpiperidine-1,3-dicarboxamide | IC50 | 12010.0 [1] |
 | 4-[(4-Cyclohexylphenyl)methyl-[2-[methyl(quinolin-8-ylsulfonyl)amino]acetyl]amino]-2-hydroxybenzoic acid | IC50 | 10000.0 [1] |
 | 6-Hydroxy-2-phenyl-3-[2-[3-(trifluoromethyl)phenyl]ethynyl]benzofuran-5-carboxylic acid | IC50 | 1400.0 [1] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Dual specificity phosphatase 22 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 12 Mar. 2026, https://www.aatbio.com/data-sets/dual-specificity-phosphatase-22-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, March 12). Quest Database™ Dual specificity phosphatase 22 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-phosphatase-22-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |